ENANTA PHARMACEUTICALS, INC Increase (Decrease) in Other Noncurrent Assets
ENANTA PHARMACEUTICALS, INC (ENTA) reported Increase (Decrease) in Other Noncurrent Assets of $18.00 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$34.00K.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $51.00K, a 1175.00% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $1.00K.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$2.00K.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other noncurrent assets for fiscal 2025 was -$2.00K.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other noncurrent assets for fiscal 2024 was -$709.00K, a 762.62% decline from fiscal 2023.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other noncurrent assets for fiscal 2023 was $107.00K, a 82.28% decline from fiscal 2022.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other noncurrent assets for fiscal 2022 was $604.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | $17.00K derived: sum of 2 quarters · filed 2026-08-12 | $18.00K 10-Q · filed 2026-08-12 | $16.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $52.00K 10-Q · filed 2026-05-13 | $50.00K derived: sum of 3 quarters · filed 2026-05-13 | $46.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $1.00K 10-Q · filed 2026-02-11 | -$1.00K derived: sum of 2 quarters · filed 2026-02-11 | -$5.00K derived: sum of 3 quarters · filed 2026-08-12 | -$1.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-09-30 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | -$6.00K derived: sum of 2 quarters · filed 2026-08-12 | -$2.00K derived: sum of 3 quarters · filed 2026-08-12 | -$2.00K 10-K · filed 2025-11-19 |
| 2025-06-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | -$11.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $4.00K 10-Q · filed 2026-05-13 | -$7.00K derived: sum of 3 quarters · filed 2026-05-13 | -$89.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 10-Q · filed 2026-02-11 | -$11.00K derived: sum of 2 quarters · filed 2026-02-11 | -$93.00K derived: sum of 3 quarters · filed 2026-02-11 | -$671.00K derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | -$93.00K derived: sum of 2 quarters · filed 2025-11-19 | -$671.00K derived: sum of 3 quarters · filed 2025-11-19 | -$709.00K 10-K · filed 2025-11-19 |
| 2024-06-30 | -$82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | -$660.00K derived: sum of 2 quarters · filed 2025-08-13 | -$698.00K 10-Q · filed 2025-08-13 | -$725.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-03-31 | -$578.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | -$616.00K 10-Q · filed 2025-05-14 | -$643.00K derived: sum of 3 quarters · filed 2025-11-19 | -$509.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-12-31 | -$38.00K 10-Q · filed 2025-02-12 | -$65.00K derived: sum of 2 quarters · filed 2025-11-19 | $69.00K derived: sum of 3 quarters · filed 2025-11-19 | $64.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-09-30 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $107.00K derived: sum of 2 quarters · filed 2025-11-19 | $102.00K derived: sum of 3 quarters · filed 2025-11-19 | $107.00K 10-K · filed 2025-11-19 |
| 2023-06-30 | $134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07 | $129.00K derived: sum of 2 quarters · filed 2024-08-07 | $134.00K 10-Q · filed 2024-08-07 | $127.00K derived: sum of 4 quarters · filed 2024-11-27 |
| 2023-03-31 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | $0.00 10-Q · filed 2024-05-08 | -$7.00K derived: sum of 3 quarters · filed 2024-11-27 | |
| 2022-12-31 | $5.00K 10-Q · filed 2024-02-08 | -$2.00K derived: sum of 2 quarters · filed 2024-11-27 | ||
| 2022-09-30 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $604.00K 10-K · filed 2024-11-27 | ||
| 2022-06-30 | $611.00K 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $0.00 10-Q · filed 2023-02-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-22 | ||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22 | $0.00 10-K · filed 2023-11-22 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | |||
| 2020-09-30 | $0.00 10-K · filed 2022-11-23 | |||
| 2018-09-30 | $92.00K 10-K · filed 2020-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |